HCPCS Level IIdrugActive
J2406
Injection, oritavancin 10 mg
BETOS: O1E
Effective: 2021-10-01
Description
Injection, oritavancin (kimyrsa), 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Kimyrsa
Manufacturer
Melinta Therapeutics, LLC
HCPCS Dosage
10 MG
Billing Units
120.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.